Back to search

Article

CRISPR activation of endogenous <i>PKD1</i> increases polycystin-1 levels and suppresses cellular features of ADPKD

2026-05-25

Abstract excerpt

Most cases of autosomal dominant polycystic kidney disease (ADPKD) are caused by mutations in PKD1, which reduce polycystin-1 (PC1) levels below a critical functional threshold. Normalizing PC1 dosage mitigates disease progression; therefore, we sought to develop a CRISPR activation (CRISPRa) strategy to transcriptionally upregulate endogenous PKD1 . We systematically screened multiple single-guide RNAs using an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
15bb778f-bf53-5239-b893-8df851056a95
DOI
10.64898/2026.05.23.727418
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR activation of endogenous <i>PKD1</i> increases polycystin-1 levels and suppresses cellular features of ADPKDDOI 10.64898/2026.05.23.727418
Select a neighboring publication to make it the new centre.